Pediatric Dermatology

Papers
(The TQCC of Pediatric Dermatology is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Chilblains in children in the setting of COVID‐19 pandemic143
Erythema multiforme‐like lesions in children and COVID‐1996
Clustered cases of acral perniosis: Clinical features, histopathology, and relationship to COVID‐1979
Varicella‐like exanthem associated with COVID‐19 in an 8‐year‐old girl: A diagnostic clue?79
Chilblain‐like lesions in children following suspected COVID‐19 infection79
Acne and social media: A cross‐sectional study of content quality on TikTok59
Disparities in telemedicine access for Spanish‐speaking patients during the COVID‐19 crisis34
Consensus recommendations for the use of retinoids in ichthyosis and other disorders of cornification in children and adolescents31
Treatment of alopecia areata in pre‐adolescent children with oral tofacitinib: A retrospective study29
Juvenile xanthogranulomas: Examining single, multiple, and extracutaneous presentations27
Epidermolysis bullosa pruriginosa treated with dupilumab26
Differences between pediatric and adult atopic dermatitis25
Management of infantile hemangiomas during the COVID pandemic25
Pediatric psoriasis and association with cardiovascular and metabolic comorbidities: Systematic review and meta‐analysis25
Vulvar aphthous ulcer after COVID‐19 vaccination24
Infections in children and adolescents treated with dupilumab in pediatric clinical trials for atopic dermatitis—A pooled analysis of trial data23
Psoriasiform dermatitis during dupilumab treatment for moderate‐to‐severe atopic dermatitis in children23
Successful management of an arteriovenous malformation with trametinib in a patient with capillary‐malformation arteriovenous malformation syndrome and cardiac compromise22
Staphylococcal scalded skin syndrome: An epidemiological and clinical review of 84 cases22
Rash as a presenting complaint in a child with COVID‐1921
Netherton syndrome: Temporary response to dupilumab21
The geographic distribution of the US pediatric dermatologist workforce: A national cross‐sectional study19
Fractional CO2 laser‐assisted topical rifamycin drug delivery in the treatment of pediatric cutaneous leishmaniasis19
Pediatric dermatology eConsults: Reduced wait times and dermatology office visits18
Characterization of wound microbes in epidermolysis bullosa: Results from the epidermolysis bullosa clinical characterization and outcomes database18
Successful treatment of chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature (CANDLE) syndrome with tofacitinib18
Pediatric teledermatology: A review of the literature16
CARD14‐associated papulosquamous eruption (CAPE) in pediatric patients: Three additional cases and review of the literature16
Efficacy of omalizumab treatment for pediatric chronic spontaneous urticaria: A multi‐center retrospective case series16
Henoch‐Schönlein purpura: Another COVID‐19 complication16
A network meta‐analysis on the efficacy and safety of monotherapies for tinea capitis, and an assessment of evidence quality15
“COVID toes”: A meta‐analysis of case and observational studies on clinical, histopathological, and laboratory findings15
Langerhans cell histiocytosis in children: A retrospective case series of 126 cases15
Dermatologic conditions in Down syndrome: A single‐center retrospective chart review15
Implementation of a pediatric provider‐to‐provider store‐and‐forward teledermatology system: Effectiveness, feasibility, and acceptability in a pilot study14
Head and neck dermatitis, a subtype of atopic dermatitis induced by Malassezia spp: Clinical aspects and treatment outcomes in adolescent and adult patients14
Financial burden of epidermolysis bullosa on patients in the United States14
Dupilumab for pediatric prurigo nodularis: A case report14
Tinea capitis: An update14
Poster Presentations14
Recurrent reactive infectious mucocutaneous eruption (RIME) in two adolescents triggered by several distinct pathogens including SARS‐CoV‐2 and influenza A14
Pediatric hematidrosis – A case report and review of the literature and pathogenesis13
Acral Changes in pediatric patients during COVID 19 pandemic: Registry report from the COVID 19 response task force of the society of pediatric dermatology (SPD) and pediatric dermatology research all13
Physical and psychosocial comorbidities of pediatric hidradenitis suppurativa: A retrospective analysis13
New‐onset head and neck dermatitis in adolescent patients after dupilumab therapy for atopic dermatitis13
Inflammatory linear verrucous epidermal nevus (ILVEN) encompasses a spectrum of inflammatory mosaic disorders12
Oral tofacitinib for the treatment of alopecia areata in pediatric patients12
Hair and skin predict cardiomyopathies: Carvajal and erythrokeratodermia cardiomyopathy syndromes12
Clinical features of recurrent Mycoplasma pneumoniae–induced rash and mucositis12
Use of spironolactone to treat acne in adolescent females12
Infliximab therapy in an infant with Netherton syndrome11
Gianotti‐crosti syndrome in the setting of recent coronavirus disease‐19 infection11
Evaluation of electronic consults for outpatient pediatric patients with dermatologic complaints11
Adenoviral‐induced rash and mucositis: Expanding the spectrum of reactive infectious mucocutaneous eruption11
Biologics for pediatric psoriasis: A systematic review and meta‐analysis11
Teledermatology: How It Is Impacting the Underserved11
TH2 sensitization in the skin‐gut‐brain axis: How early‐life Th2‐mediated inflammation may negatively perpetuate developmental and psychologic abnormalities11
Clinical characteristics associated with increased wound size in patients with recessive dystrophic epidermolysis bullosa11
Assessing vaccination reactions in pediatric patients with maculopapular cutaneous mastocytosis11
Clearance of pediatric actinic prurigo with dupilumab11
The anatomic distribution of isolated and syndrome‐associated port‐wine stain10
Association between atopic dermatitis and headaches throughout childhood and adolescence—A longitudinal birth cohort study10
Understanding sunscreen and photoprotection misinformation on parenting blogs: A mixed‐method study10
Linear porokeratosis with bone abnormalities treated with compounded topical 2% cholesterol/2% lovastatin ointment10
A comparative study of the efficacy and safety of intralesional measles, mumps, and rubella vaccine versus intralesional vitamin D3 for the treatment of warts in children10
Dermatologic conditions in Down syndrome10
Pediatric drug reaction with eosinophilia and systemic symptoms: A systematic review of the literature, with a focus on relapsing cases10
Clearance of atypical cutaneous manifestations of hyper‐IgE syndrome with dupilumab10
When is synchronous telehealth acceptable for pediatric dermatology?10
Long‐term sirolimus treatment in blue rubber bleb nevus syndrome: Case report and review of the literature10
Bier anemic spots, cyanosis, and urticaria‐like eruption (BASCULE) syndrome: Report of two new cases and literature review10
Nevus comedonicus syndrome: A systematic review of the literature10
Systemic immunosuppressive therapy for inflammatory skin diseases in children: Expert consensus‐based guidance for clinical decision‐making during the COVID‐19 pandemic10
Prevalence of inflammatory bowel disease among pediatric patients with hidradenitis suppurativa and the potential role of screening with fecal calprotectin10
Primary hyperhidrosis in children: A review of therapeutics10
Predictors and age‐dependent pattern of psychologic problems in childhood atopic dermatitis10
A practical review of dermoscopy for pediatric dermatology part II: Vascular tumors, infections, and inflammatory dermatoses10
A novel SPINK5 mutation and successful subcutaneous immunoglobulin replacement therapy in a child with Netherton syndrome9
Spectrum of autoimmune bullous diseases among children in Kuwait9
Congenital infiltrating lipomatosis of the face with lingual mucosal neuromas associated with a PIK3CA mutation9
Papulo‐purpuric dermatitis of childhood: a distinct PLEVA‐like eruption associated to SARS‐CoV‐2 infection. Clinical, histopathological and immunohistochemical study of 10 cases9
Experience using dupilumab for pediatric atopic dermatitis at a tertiary care c enter: Inadequate response and adverse events9
Monkeypox disease in a breastfeeding infant9
A sixteen‐year single‐center retrospective chart review of Spitz nevi and spitzoid neoplasms in pediatric patients9
Epidermolysis bullosa with congenital absence of skin: Review of the literature9
The positive environmental impact of virtual isotretinoin management9
Barriers to healthcare access in pediatric dermatology: A systematic review9
Hidradenitis suppurativa and Down syndrome: A systematic review and meta‐analysis9
Cutaneous body image: A window into the adolescent experience of dermatologic disease9
Reactive infectious mucocutaneous eruption in children diagnosed with COVID‐199
Comment on “Chilblains‐like lesions in children following suspected COVID‐19 infection”8
Epidermolysis bullosa simplex due to bi‐allelic DST mutations: Case series and review of the literature8
Contrasting readability and availability of Spanish language with English language patient education materials8
Improving newborn skin health: Effects of diaper care regimens on skin pH and erythema8
Photographic representation of skin tones in three dermatology journals8
Evaluation of emergency department utilization for dermatologic conditions in the pediatric population within the United States from 2009‐20158
Alopecia universalis after drug reaction with eosinophilia and systemic symptoms (Dress)8
POSTER PRESENTATIONS8
Recurrent angioedema in childhood: hereditary angioedema or histaminergic angioedema?8
Dermatologic considerations for transgender and gender diverse youth8
Is prolonged monitoring necessary? An updated approach to infantile hemangioma treatment with oral propranolol8
Dermatofibrosarcoma protuberans, fibrosarcomatous variant: A rare tumor in children8
Toxic epidermal necrolysis and Stevens‐Johnson syndrome/toxic epidermal necrolysis overlap in pediatric patients with a focus on newer antiepileptic drugs: A 25‐year retrospective study at a single te8
Chilblains in children in the time of COVID‐19: New evidence with serology assay8
Paradoxical psoriasis in pediatric patients: A systematic review8
Comparison of lichen sclerosus in boys and girls: A systematic literature review of epidemiology, symptoms, genetic background, risk factors, treatment, and prognosis8
Suspected COVID‐19‐related reticulated purpura of the soles in an infant7
Light‐based treatment of pediatric port‐wine birthmarks7
Review of traction alopecia in the pediatric patient: Diagnosis, prevention, and management7
Metastatic neuroblastoma mimicking an infantile hemangioma7
Publication productivity (H‐Index) among pediatric dermatologists in the United States7
Evaluation of neurodevelopmental symptoms in 10 cases of neonatal ichthyosis and sclerosing cholangitis syndrome7
Generalized eczematous dermatitis and pruritus responsive to dupilumab in a patient with immune dysregulation, polyendocrinopathy, enteropathy, X‐linked (IPEX) syndrome7
Pediatric maculopapular cutaneous mastocytosis: Retrospective review of signs, symptoms, and associated conditions7
Keratosis pilaris‐like eruption secondary to nilotinib in a child7
Clinical and genetic evaluation of six children with diffuse capillary malformation and undergrowth7
Patient‐reported outcomes and quality of life in dominant dystrophic epidermolysis bullosa: A global cross‐sectional survey7
Chronic urticaria in children under 15 years of age: Clinical experience beyond the clinical trials7
Filling in the gaps on FILS syndrome: A case report and literature review7
Geographic distribution and characteristics of the pediatric dermatology workforce in the United States7
Acute urticaria preceding other COVID‐19–associated manifestations—A case report7
Atopic dermatitis and skin infections are a poorly documented crisis in Canada's Indigenous pediatric population: It's time to start the conversation7
Eosinophilic cellulitis in response to BNT162b2 COVID‐19 vaccination6
Angioedema: A potential complication of dupilumab in atopic dermatitis6
BASCULE syndrome in a child with prior asymptomatic COVID‐19 infection6
Infliximab for the treatment of recalcitrant bullous Sweet syndrome in a 10‐year‐old girl6
Efficacy and safety of ritlecitinib in adolescents with alopecia areata: Results from the ALLEGRO phase 2b/3 randomized, double‐blind, placebo‐controlled trial6
Dermatofibrosarcoma protuberans (DFSP) in children: A combined multidisciplinary approach6
A case of wild‐type rubella‐associated cutaneous granuloma in ataxia telangiectasia6
The natural history of laryngo‐onycho‐cutaneous syndrome: A case series of six pediatric patients and literature review6
Toxic epidermal necrolysis after first dose of Pfizer‐BioNTech (BNT162b2) vaccination with pharmacogenomic testing6
Retrospective review of confluent and reticulated papillomatosis in pediatric patients6
Cutaneous lipomas and macrocephaly as early signs of PTEN hamartoma tumor syndrome6
Methotrexate for inflammatory skin disease in pediatric patients: Consensus treatment guidelines6
Topical cidofovir for the treatment of recalcitrant viral warts and molluscum contagiosum in Jacobsen syndrome6
Readability of online patient education materials for juvenile dermatomyositis6
Pediatric epidermolysis bullosa acquisita: A review6
Manifestation of anxiety and depression among pediatric patients with psoriasis: A review6
Propranolol's effects on the sleep of infants with hemangiomas: A prospective pilot study6
Treatment practices in the management of scabies in infants younger than two months6
Successful treatment of a 3‐year‐old girl with generalized pustular psoriasis using secukinumab monotherapy6
Worsening ulceration of infantile hemangioma after initiation or escalation of propranolol6
Early initiation of treatment with oral propranolol for infantile hemangioma improves success rate6
Continuing patient care to underserved communities and medical education during the COVID‐19 pandemic through a teledermatology student‐run clinic6
Infantile toxic epidermal necrolysis: Successful treatment of an 8‐week‐old with intravenous immunoglobulin and amniotic membrane transplant6
Language‐centered approach to care improvement in a pediatric dermatology clinic6
A systematic scoping review of racial, ethnic, and socioeconomic health disparities in pediatric dermatology6
Disparities in telemedicine use during the COVID‐19 pandemic among pediatric dermatology patients6
Vulvar vitiligo and lichen sclerosus in children: A clinical challenge6
Ichthyosis follicularis, atrichia and photophobia (IFAP) and hereditary mucoepithelial dysplasia: Two syndromes that share a common clinical spectrum6
6
Learning to pop blisters in epidermolysis bullosa with a simple model6
Diagnosing Omenn syndrome6
Improvement in disease severity and pruritus outcomes with crisaborole ointment, 2%, by baseline atopic dermatitis severity in children and adolescents with mild‐to‐moderate atopic dermatitis6
“Accutane Check”: Insights into youth sentiment toward isotretinoin from a TikTok trend6
Proliferating pilomatricoma in a 9‐year‐old girl6
Genomic comparison of malignant melanoma and atypical Spitz tumor in the pediatric population6
Necrobiosis lipoidica with rapid response to doxycycline6
Clinical, trichoscopy, and light microscopic findings in hypohidrotic ectodermal dysplasia: Report of 21 patients and a review of the literature6
Treatment of pruritus with botulinum toxin in a pediatric patient with Fox‐Fordyce disease5
Epidermolysis bullosa with pyloric atresia associated with compound heterozygous ITGB4 pathogenic variants: Minimal skin involvement but severe mucocutaneous disease5
Skin and Mucosal Manifestations in NEMO Syndrome: A Case Series and Literature Review5
Photodocumentation in skin of color5
Folliculocystic and collagenous hamartoma of tuberous sclerosis complex, not always a single cutaneous lesion5
Retrospective case series of increased oral propranolol dosage for infantile hemangiomas5
Cutaneous reactions to pediatric cancer treatment part II: Targeted therapy5
Pediatric morphea state‐of‐the‐art literature review: Reframing morphea as a systemic disease5
Staphylococcal toxic shock syndrome in a child with interleukin‐17 inhibitor treatment for psoriasis5
A novel ENPP1 mutation identified in a multigenerational family affected by Cole disease5
Hereditary fibrosing poikiloderma (POIKTMP syndrome) report of a new mutation and review of the literature5
Pachydermodactyly associated with extensive computer gaming: A report of three cases5
Parental atopy and risk of atopic dermatitis in the first two years of life in the BASELINE birth cohort study5
Pruritus assessment tools for 6 to 7‐year‐old children: KidsItchyQoL and ItchyQuant5
Pediatric primary cutaneous anaplastic large cell lymphoma treated with brachytherapy5
Transient abdominal telangiectasia of the newborn5
Acral peeling as the sole skin manifestation of COVID‐19 in children5
Keratinocytic epidermal nevi associated with localized fibro‐osseous lesions without hypophosphatemia5
Demographic characteristics, clinical features, and optimal management of hospitalized patients with staphylococcal scalded skin syndrome5
That’s Not Molluscum! A literature review of 109 cases of subepidermal calcified nodules5
Rapid response to secukinumab in a 5‐year‐old with deficiency of the interleukin‐36 receptor antagonist (DITRA) with severe scalp and nail involvement5
PLACK syndrome resulting from a novel homozygous variant in CAST5
Disseminated cutaneous tuberculosis from BCG vaccination site in an immunocompetent child5
Management of tinea capitis in Israel: A comparative study5
Successful treatment of a child's pityriasis rubra pilaris (PRP) with ustekinumab and acitretin5
Widespread cutaneous eruption after aluminum‐containing vaccination: A case report and review of current literature5
Anogenital warts and relationship to child sexual abuse: Systematic review and meta‐analysis5
Skin of color images in pediatric dermatology textbooks5
Duration of neonatal intensive care unit exposure associated with decreased risk of atopic dermatitis5
Short anagen syndrome: A case series and algorithm for diagnosis5
Psychosocial impact of epidermolysis bullosa on patients: A qualitative study5
Catastrophic congenital hemangioma with severe coagulopathy leading to fatal cardiac failure: Case report and review5
Interventions to improve primary care provider management of atopic dermatitis: A systematic review5
Low dose oral corticosteroids, microneedling, and topical 5‐fluorouracil: A novel treatment for recalcitrant pediatric vitiligo5
Multifocal infantile hemangiomas associated with concomitant giant hepatic rapidly involuting congenital hemangioma5
Tips for addressing common conditions affecting pediatric and adolescent patients with skin of color5
Patch testing in skin of color: A brief report5
Decreases in scabies and lice cases among the pediatric and adult populations during COVID‐195
Thoracoscopic sympathicotomy for the treatment of intolerable palmar and axillary hyperhidrosis in children is associated with high recurrence rates5
Evolution of incidence of chilblain‐like lesions in children during the first year of COVID‐19 pandemic5
Acute generalized exanthematous pustulosis in children and adolescents in Singapore: A ten‐year retrospective review4
Inflammatory bowel disease presenting with pyodermatitis‐pyostomatitis vegetans in a pediatric patient: A case report and review of the literature4
Pediatric melanoma in the Hispanic population: An analysis of institutional and national data4
Report of a case of RAVEN, hair heterochromia and autism in the setting of FGFR2 mutation4
A case of inflammatory linear verrucous epidermal nevus successfully treated with Brodalumab4
Review article: Emerging issues in pediatric skin of color, part 14
Perineal desquamation: An early sign of the Kawasaki disease phenotype of MIS‐C4
Generalized infantile myofibromatosis with visceral involvement presenting as diffuse hypopigmented macules at birth4
Influence of gender and sexual identity on adolescent skin health4
A case of pediatric lymphomatoid papulosis treated with photodynamic therapy and narrowband ultraviolet B4
Development of an artificial intelligence algorithm for the diagnosis of infantile hemangiomas4
Pediatric trichodysplasia spinulosa: A report of 2 cases and review of the literature4
Switching biologics in children with psoriasis: Results from the BiPe cohort4
Cutaneous hyperpigmentation following bleomycin sclerotherapy for vascular malformations4
Parent report of sleep health and attention regulation in a cross‐sectional study of infants and preschool‐aged children with atopic dermatitis4
Periorbital hypopigmentation and telangiectasias: Clues to diagnosing neonatal lupus in skin of color4
4
Acquired epidermodysplasia verruciformis (AEV) in three children after cardiac transplantation: A case series and review of the literature4
A case of severe nivolumab‐induced lichen planus pemphigoides in a child with metastatic spitzoid melanoma4
Hematohidrosis of the mid‐face and hands treated with oral oxybutynin4
Improving patient education for atopic dermatitis: A randomized controlled trial of a caregiver handbook4
Delayed diagnosis of holocarboxylase synthetase deficiency in three patients with prominent skin findings4
Examination of use and barriers for five sun protection strategies in parents and their children4
Facial hemihypertrophy in a girl with sturge‐weber syndrome: Treatment with oral sirolimus4
Combined antibiotic, steroid, and moisturizer for atopic dermatitis: A two‐year case series of patient‐reported outcomes4
Alopecia in children undergoing chemotherapy, radiation, and hematopoietic stem cell transplantation: Scoping review and approach to management4
A unique variant of juvenile papular‐purpuric gloves and socks syndrome4
Cutaneous manifestations of obesity in Turkish children: A comparative study4
Do clinical severity scores correlate with the quality of life in children with psoriasis? A cross‐sectional study of Iranian pediatric patients4
Autoimmune progesterone dermatitis in the adolescent population4
Reflectance confocal microscopy in pediatric dermatology: A state‐of‐the‐art review4
Cutaneous granulomas as the presenting manifestation of Griscelli syndrome type 24
Skin concerns in patients with trisomy 21 (Down syndrome): A Mayo Clinic 22‐year retrospective review4
A fatal case of malignant atrophic papulosis in a pediatric patient4
Efficacy of procedural treatments for pediatric hidradenitis suppurativa: A systematic review4
A case of prolidase deficiency in a male patient4
Tinea faciei caused by Trichophyton benhamiae in a child4
Acute inflammatory Demodex‐induced pustulosis in an immunocompetent patient related to topical steroid use4
Topical rapamycin for acanthosis nigricans in the Fitzpatrick IV/V adolescent population4
The spectrum of pediatric scarring alopecia: A retrospective review of 27 patients seen at Mayo Clinic4
Atopic dermatitis‐like graft‐versus‐host disease treated with dupilumab4
The scope of health insurance coverage of vitiligo treatments in the United States: Implications for health care outcomes and disparities in children of color4
Treatment of scarring alopecia from trauma and surgical procedures in young patients using follicular unit hair transplantation4
Topical corticosteroids for noninvasive treatment of pyogenic granulomas4
Intralesional steroid injections for inflammatory nail dystrophies in the pediatric population4
A case report of PHF6 mosaicism: Beyond the classic Börjeson‐Forssman‐Lehmann syndrome4
Heterogeneous cutaneous findings associated with intrauterine HSV infection: A case series and literature review4
Comparing clinical acne vulgaris severity to adolescent and parent perceptions of acne severity and impact on quality of life4
Atypical aplasia cutis in association with Xia Gibbs syndrome3
Perspectives and knowledge of acne vulgaris among young adolescents3
Transepidermal water loss in the orphan forms of ichthyosis3
0.05745005607605